Roche Chairman Slams US Tariff Threats as 'Cold-Blooded Blackmail', Flags Rising Protectionism Risks

Written By :  sheeba farhat
Published On 2026-06-07 04:30 GMT   |   Update On 2026-06-07 04:30 GMT
Advertisement

Zurich: The chairman of Swiss pharmaceutical giant Roche hit out at U.S. tariff policies on Thursday, likening them to "blackmail", and said protectionism by the United States ‌and China ⁠was ⁠the firm's biggest geopolitical concern.

Severin Schwan was asked about the agreement his firm struck with the Trump administration late last year to slash prices for medicines in the United States after U.S. officials had threatened to ⁠impose steep ‌tariffs on drugmakers.

"If someone ​points ​a gun at you and ⁠says 'if you don't sign, there'll be 200% tariffs ​tomorrow', I wouldn't necessarily describe that ​as a deal," Schwan said in an interview at an event in the Swiss city of Interlaken, broadcast on Swiss television.

"So in a legal sense ‌that's perhaps an agreement, but it's basically cold-blooded blackmail," he added.

The Trump ​administration argues ​that foreign ⁠companies have taken advantage of the United States to overcharge U.S. consumers for medicines, and it ​has sought to encourage more production there.

Separately, Schwan identified protectionism by the United States and China as the firm's biggest geopolitical worry.

Also Read: Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News